Clinical Trials Browser

Interventional × Hodgkin Disease × Thalidomide × Clear all

NCT00209014 2009-05-07

Phase II Trial of Thalidomide in Refractory/Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin's Disease

Phase 2 Terminated

Hodgkin Disease, Lymphoma, B-Cell